Fumihiko Kanai
- Molecular Biology top 1%
- Hepatology top 0.2%
- Epidemiology top 1%
- Oncology top 1%
- Surgery top 2%
- Co-authors
- Masao OmataTakao KawabeTsuneo IkenoueNaoya KatoYasushi ShiratoriKeisuke TateishiYasuo TanakaMichael B. Yaffe
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (48 papers)Liver Disease Diagnosis and Treatment (28 papers)Hepatitis C virus research (15 papers)
- Cited by
- HepatologyCell BiologyOncology
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Fumihiko Kanai
158 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 4.3k
- Hepatology 2.1k
- Epidemiology 1.8k
- Oncology 1.8k
- Surgery 1.4k
Countries citing papers authored by Fumihiko Kanai
This map shows the geographic impact of Fumihiko Kanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihiko Kanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihiko Kanai more than expected).
Fields of papers citing papers by Fumihiko Kanai
This network shows the impact of papers produced by Fumihiko Kanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihiko Kanai. The network helps show where Fumihiko Kanai may publish in the future.
Co-authorship network of co-authors of Fumihiko Kanai
This figure shows the co-authorship network connecting the top 25 collaborators of Fumihiko Kanai. A scholar is included among the top collaborators of Fumihiko Kanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihiko Kanai. Fumihiko Kanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 9 | |
| 3 | 19 | |
| 4 | 1 | |
| 5 | 81 | |
| 6 | 21 | |
| 7 | 74 | |
| 8 | 13 | |
| 9 | 83 | |
| 10 | 78 | |
| 11 | 124 | |
| 12 | 47 | |
| 13 | TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteinsbreakdown → | 625 |
| 14 | 40 | |
| 15 | 214 | |
| 16 | 19 | |
| 17 | 37 | |
| 18 | 63 | |
| 19 | 54 | |
| 20 | 239 |
About Fumihiko Kanai
Fumihiko Kanai is a scholar working on Hepatology, Cancer Research and Biotechnology, having authored 158 papers that have together received 8.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis C virus research (15 papers). The work is most often cited by research in Hepatology (2.1k citations), Cell Biology (1.1k citations) and Oncology (1.8k citations). Fumihiko Kanai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masao Omata, Takao Kawabe, Tsuneo Ikenoue, Naoya Kato, Yasushi Shiratori, Keisuke Tateishi, Yasuo Tanaka, Michael B. Yaffe, Shuichiro Shiina and Jun Imamura. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.